Abstract
Metabolic gene polymorphisms encode for enzymes which are involved in both metabolism and conjugation of environmental as well endogenous compounds. Some of the products of the metabolic process are carcinogens. Two main categories of metabolic genes are known: Phase I genes, which include CYP1A1, CYP2E1, CYP2D6, and Phase II genes, such as GSTM1, GSTT1, NAT2. Polymorphisms have been described in these genes, with different frequencies according to ethnicity and geographic area.1 Several case-control studies have been conducted to study the association between metabolic gene polymorphisms and cancer of various sites, with special focus on lung and bladder cancer. It has been suggested that these genes play a role in cancer risk only when they interact with environmental exposure, since the substrates of their gene products are xenobiotic chemicals or their metabolites.2 This form of gene-environment interaction (GEI) has been described as “Type 2” GEI by Khoury3 and Ottman.4 According to this model, the presence or absence of the genetic risk factor is irrelevant for disease causation, if there is no exposure to an environmental agent. When the dose of environmental exposure (such as smoking) is analyzed with respect to metabolic susceptibility gene polymorphisms, two patterns are seen. In one case, a low exposure-gene (LEG) effect is observed, in which a decreasing degree of interaction occurs as a function of increasing exposure dose. A high exposure-gene (HEG) effect is observed when there is an increased degree of interaction as a function of exposure dose.2
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Garte S.J., Trachman J., Crofts E, Taioli E., Toniolo P., Buxbaum J., and Bayo S. CYP1A1 genotypes in African-Americans and Caucasians. Human Heredity 46, 121–127, 1996.
Taioli E., Zocchetti C., and Garte S.J. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environm. Health Persp. 106, 67–70, 1998.
Khoury M.J. and James L.M. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol. 137, 1241–50, 1993.
Ottman R. An epidemiologic approach to gene-environment interaction. Genet. Epidemiol. 7, 177–185, 1990.
London S.J., Daly A.K., Cooper J., Navidi W.C., Carpenter C.L., and Idle J.R. Polymorphism of glutathione S-transferase Ml and lung cancer risk among African-Americans and Caucasians in Los Angeles county, California. JNCI, 87, 1246–1253,1995.
Kihara M., Noda K., and Kihara M. Distribution of GSTM1 null genotype in relation to gender, age, and smoking status in Japanese lung cancer patients. Pharmacogenetics 5, S74 - S79, 1995.
Brockmoller J., Kerb R., Drakoulis N., Nitz M., and Roots I. Genotype of glutatione S-transferase class µ isoenzymes t and `P in lung cancer patients and controls. Cancer Research, 53, 1004–1011, 1993.
Nakachi K., Imai K., Hayashi S., Wtanabe J., and Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research, 51, 5177–5180, 1991.
Sugimura H. Suzuki I. Hamada G.S., Iwase T., Takahashi T., Nagura K., Iwata H. Watanabe S., Kino I. and Tsugane S. Cytochrome P-450 1A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidem Biom Prey, 3,145–148,1994.
London S.J., Daly A.K., and Fairbrother K.S. Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Research, 55, 6035–6037, 1995.
Taioli E., Crofts E, Trachman J., Demopoulos R., and Garte SJ. A specific African-American polymorphism is associated with adenocarcinoma of the lung. Cancer Research, 55, 472–73, 1995.
Taioli E., Ford J., Trachman J., Li Y., Demopoulos R. and Garte S. Lung cancer risk and CYP1A1 genotype in African-Americans. Carcinogenesis, 19: 813–18, 1998.
Kelsey K.T., Wiencke J.K., and Spitz M.R. A race-specific genetic polymorphismin the CYP1A1 gene is not associated with lung cancer in African-Americans. Carcinogenesis 15, 1121–1124, 1994.
Nakachi K., Imai K., Hayashi S., and Kawajiri K. Polymorphisms of the CYP1A1 and glutathione Stransferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research, 53, 2994–2999, 1993.
Kihara M., Kihara M., and Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis, 16, 2331–2336, 1995.
Bernardini S., Hirvonen A., Pelin K., and Norppa H. Induction of sister chromatid exchange by 1,2- epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis, 19, 377–80, 1998.
Uuskula M., Jarventaus H., Hirvonen A., Orsa M., and Norppa H. Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis, 16, 947–50, 1995.
Norppa H., Hirvonen A., Jarventaus H., Uuskula M.,Tasa G., Ojajarvi A., and Sorsa M. Role of GSTTl and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis, 16, 1261–64, 1995.
Merlo F, Andreassen A., Weston A., Pan C.-F., Haugen A., Valerio E, Reggiardo G., Fontana V., Garte S., Puntoni R., and Abbondandolo A. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of plycyclic aromatic hydrocarbons. Cancer Epidemiol Biomark Prevent, 7, 147–155, 1998.
Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int. J. Cancer, 71, 1–3, 1997.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Taioli, E., Garte, S. (1999). Low Dose Exposure to Carcinogens and Metabolic Gene Polymorphisms. In: Zappia, V., Della Ragione, F., Barbarisi, A., Russo, G.L., Iacovo, R.D. (eds) Advances in Nutrition and Cancer 2. Advances in Experimental Medicine and Biology, vol 472. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3230-6_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3230-6_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3331-7
Online ISBN: 978-1-4757-3230-6
eBook Packages: Springer Book Archive